These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24356635)

  • 1. The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.
    Rossi CR; Mozzillo N; Maurichi A; Pasquali S; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Mocellin S; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M
    Ann Oncol; 2014 Jan; 25(1):240-6. PubMed ID: 24356635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.
    Rossi CR; Mozzillo N; Maurichi A; Pasquali S; Macripò G; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Mocellin S; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M
    JAMA Surg; 2014 Jul; 149(7):700-6. PubMed ID: 24804856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph-Node Ratio in Patients with Cutaneous Melanoma: A Multi-Institution Prognostic Study.
    Sandro P; Andrea M; Nicola M; Simone M; Giuseppe M; Lorenzo B; Nicola S; Dario P; Luigi M; Giuseppe G; Roberto P; Corrado C; Simone R; Ugo M; Mario S; Riccardo RC
    Ann Surg Oncol; 2015 Jul; 22(7):2127-34. PubMed ID: 25316489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population.
    Spillane AJ; Haydu L; McMillan W; Stretch JR; Thompson JF
    Ann Surg Oncol; 2011 Sep; 18(9):2521-8. PubMed ID: 21556951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma.
    Grotz TE; Huebner M; Pockaj BA; Perkins S; Jakub JW
    Ann Surg Oncol; 2013 Dec; 20(13):4370-7. PubMed ID: 24046102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic lymph node status prediction in melanoma patients with inguinal lymph node metastasis.
    Pasquali S; Mocellin S; Bigolin F; Vecchiato A; Montesco MC; Di Maggio A; Rossi CR
    Melanoma Res; 2014 Oct; 24(5):462-7. PubMed ID: 24999756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage III thick (>4.0 mm) lower extremity melanoma: is timing of lymph node involvement a prognostic factor?
    Herman K; Wysocki WM; Skotnicki P; Tabor J; Luczyńska E; Komorowski AL
    World J Surg; 2009 Mar; 33(3):469-74. PubMed ID: 19148700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
    Tas F; Erturk K
    Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Judging the therapeutic value of lymph node dissections for melanoma.
    Chan AD; Essner R; Wanek LA; Morton DL
    J Am Coll Surg; 2000 Jul; 191(1):16-22; discussion 22-3. PubMed ID: 10898179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma.
    Tas F; Erturk K
    Ann Plast Surg; 2019 Oct; 83(4):455-458. PubMed ID: 31524742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.
    Bagaria SP; Ray PS; Joseph RW; Heckman MG; Rawal B; Gray RJ; Pockaj B; Wasif N
    Cancer; 2013 May; 119(10):1860-7. PubMed ID: 23408288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
    Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
    Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.
    Galliot-Repkat C; Cailliod R; Trost O; Danino A; Collet E; Lambert D; Vabres P; Dalac S
    Eur J Surg Oncol; 2006 Sep; 32(7):790-4. PubMed ID: 16822643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.